B-Cell Linker (BLNK) (N-Term) Peptid
BLNK
Reaktivität: Human
Wirt: Synthetic
BP, WB
Produktnummer ABIN5512763
Kurzübersicht für B-Cell Linker (BLNK) (N-Term) Peptid (ABIN5512763)
Target
B-Cell Linker (BLNK)
Spezies
Human
Quelle
Synthetic
Applikation
Blocking Peptide (BP), Western Blotting (WB)
-
-
Protein Region
- N-Term
-
Sequenz
- ADEEEQWSDD FDSDYENPDE HSDSEMYVMP AEENADDSYE PPPVEQETRP
-
Produktmerkmale
- This is a synthetic peptide designed for use in combination with anti- BLNK Antibody. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
-
-
-
-
Applikationshinweise
- Optimal working dilution should be determined by the investigator.
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Lyophilized
-
Rekonstitution
- Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
-
Lagerung
- -20 °C
-
Informationen zur Lagerung
- For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
-
-
- B-Cell Linker (BLNK)
-
Hintergrund
-
This gene encodes a cytoplasmic linker or adaptor protein that plays a critical role in B cell development. This protein bridges B cell receptor-associated kinase activation with downstream signaling pathways, thereby affecting various biological functions. The phosphorylation of five tyrosine residues is necessary for this protein to nucleate distinct signaling effectors following B cell receptor activation. Mutations in this gene cause hypoglobulinemia and absent B cells, a disease in which the pro- to pre-B-cell transition is developmentally blocked. Deficiency in this protein has also been shown in some cases of pre-B acute lymphoblastic leukemia. Alternatively spliced transcript variants have been found for this gene.
Alias Symbols: bca, AGM4, BASH, LY57, SLP65, BLNK-S, SLP-65
Protein Size: 456 -
Gen-ID
- 29760
-
NCBI Accession
- NM_001114094, NP_001107566
-
UniProt
- Q8WV28
Target
-
Sie sind hier:
